Intubation in Coronavirus Disease 19 With Level 3 PPE
The Intubation Procedure in COVID-19 Pandemic
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Dita Aditianingsih
- Phone Number: +6281316114154
- Email: ditaaditia@gmail.com
Study Locations
-
-
DKI Jakarta
-
Jakarta Pusat, DKI Jakarta, Indonesia, 10430
- Cipto Mangunkusumo Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18 to 59 years old
- Undergo elective or emergency surgery using general anesthesia with endotracheal tube
- BMI below 30 kg/m2
Exclusion Criteria:
- Airway difficulty as assessed by preoperative assessment
- Critical patients with unstable hemodynamics
- Suspected or confirmed COVID-19 with ASA 3-5
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Group 1 - Level 3 PPE and video laryngoscope
Pre-anesthesia visit aims to assess the participant's physical status based on the American Society of Anesthesiologists score and assessment of the airway.
Researcher then explained about the study and plan for anesthesia using an endotracheal tube and personal protective equipment according to the group.
While in the operating room, the intubation operator was assisted by an assistant who already used appropriate PPE.
Coveralls or hazmat suits and surgical gowns used must match the size.
The intubation operator was resident of Anesthesiology and Intensive Therapy study program (stage II) and accompanied by an independent resident (stage III) and an anesthesiologist on duty.
The operator used level 3 PPE (coverall jumpsuit, face shield, goggles, N95 mask, surgical mask, boot, scrub, and two layered gloves) and video laryngoscope for intubation of the participants.
Researcher was in charge for recording time and event during the intubation process according to the study form.
|
The operator used level 3 PPE and video laryngoscope for the intubation process
|
|
Experimental: Group 2 - Level 3 PPE and direct laryngoscope
Pre-anesthesia visit aims to assess the participant's physical status based on the American Society of Anesthesiologists score and assessment of the airway.
Researcher then explained about the study and plan for anesthesia using an endotracheal tube and personal protective equipment according to the group.
While in the operating room, the intubation operator was assisted by an assistant who already used appropriate PPE.
Coveralls or hazmat suits and surgical gowns used must match the size.
The intubation operator was resident of Anesthesiology and Intensive Therapy study program (stage II) and accompanied by an independent resident (stage III) and an anesthesiologist on duty.
The operator used level 3 PPE (coverall jumpsuit, face shield, goggles, N95 mask, surgical mask, boot, scrub, and two layered gloves) and direct laryngoscope for intubation of the participants.
Researcher was in charge for recording time and event during the intubation process according to the study form.
|
The operator used level 3 PPE and direct laryngoscope for the intubation process
|
|
Experimental: Group 3 - Level 2 PPE and direct laryngoscope
Pre-anesthesia visit aims to assess the participant's physical status based on the American Society of Anesthesiologists score and assessment of the airway.
Researcher then explained about the study and plan for anesthesia using an endotracheal tube and personal protective equipment according to the group.
While in the operating room, the intubation operator was assisted by an assistant who already used appropriate PPE.
Coveralls or hazmat suits and surgical gowns used must match the size.
The intubation operator was resident of Anesthesiology and Intensive Therapy study program (stage II) and accompanied by an independent resident (stage III) and an anesthesiologist on duty.
The operator used level 2 PPE (surgical gown/apron, face shield, goggles, N95 mask, surgical mask, boot, scrub, and two layered gloves) and video laryngoscope for intubation of the participants.
Researcher was in charge for recording time and event during the intubation process according to the study form.
|
The operator used level 2 PPE and direct laryngoscope for the intubation process
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total duration of the intubation process
Time Frame: During the procedure
|
The sum amount of time needed to complete an intubation process that includes preoxygenation duration, neuromuscular blocker action, laryngoscopy duration, and endotracheal tube position confirmation with ultrasound
|
During the procedure
|
|
Success of intubation process as assessed by number of trials
Time Frame: During the procedure
|
The sum amount of trials needed to successfully place an endotracheal tube to the respiratory system
|
During the procedure
|
|
Safety as assessed by number of participants experiencing complications
Time Frame: During the procedure
|
Number of participants who experience desaturation of oxygen (below 95%), airway injury, increased blood pressure (over 120/80 mmHg)
|
During the procedure
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Dita Aditianingsih, Indonesia University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- IndonesiaU120
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.